137 related articles for article (PubMed ID: 34733157)
1. Effect of Mahuang Fuzi and Shenzhuo Decoction on Idiopathic Membranous Nephropathy: A Multicenter, Nonrandomized, Single-Arm Clinical Trial.
Dong Z; Dai H; Gao Y; Jiang H; Liu M; Liu F; Liu W; Feng Z; Zhang X; Ren A; Li X; Rui H; Tian X; Li G; Liu B
Front Pharmacol; 2021; 12():724744. PubMed ID: 34733157
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial.
Zhang N; Jiang H; Dai H; Huang S; Zhao Q; Zhang N; Liu W; Dong Z; Gao Y; Dong X; Hu Y; Hou F; Rui H; Liu Q; Liu B
Ren Fail; 2024 Dec; 46(1):2320834. PubMed ID: 38482580
[TBL] [Abstract][Full Text] [Related]
3. Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage.
Zhao Q; Dai H; Jiang H; Zhang N; Hou F; Zheng Y; Gao Y; Liu W; Feng Z; Hu Y; Tang X; Rui H; Liu B
Biomed Pharmacother; 2024 May; 174():116583. PubMed ID: 38626520
[TBL] [Abstract][Full Text] [Related]
4. The Ameliorative Effect of Mahuang Fuzi and Shenzhuo Decoction on Membranous Nephropathy of Rodent Model is Associated With Autophagy and Wnt/β-Catenin Pathway.
Gao Y; Dai H; Zhang N; Jiang H; Zhang Z; Feng Z; Dong Z; Liu W; Liu F; Dong X; Zhao Q; Zhou X; Du J; Zhang N; Rui H; Liu B
Front Pharmacol; 2022; 13():820130. PubMed ID: 35529432
[TBL] [Abstract][Full Text] [Related]
5. Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time.
Zhang N; Dai H; Dong X; Liu W; Jiang H; Zhao Q; Gao Y; Feng Z; Dong Z; Hu Y; Huang G; Rui H; Liu B
Front Immunol; 2022; 13():926368. PubMed ID: 35983038
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of Mahuang Fuzi Xixin Decoction formula syndromes based on severe cases of critical care and its application for nosocomial infection in critical care medicine including hyperpyrexia after tracheotomy and severe pain accompanied by acute myocardial infarction and diabetic peripheral neuropathy].
Xiong XJ
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(18):3869-3875. PubMed ID: 31872717
[TBL] [Abstract][Full Text] [Related]
7. Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/
Dai H; Liu F; Qiu X; Liu W; Dong Z; Jia Y; Feng Z; Liu Z; Zhao Q; Gao Y; Zhang Z; Gao C; Sun S; Tian X; Liu B
Evid Based Complement Alternat Med; 2020; 2020():7809427. PubMed ID: 32963573
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analysis of volatile oils of Mahuang Fuzi Xixin decoction and its major constituted herbs by GC-MS].
Liang SY; Tan XM; Chen FL; Luo JB
Zhong Yao Cai; 2011 Jun; 34(6):896-901. PubMed ID: 22017005
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
Chen Y; Deng Y; Ni Z; Chen N; Chen X; Shi W; Zhan Y; Yuan F; Deng W; Zhong Y
Am J Kidney Dis; 2013 Dec; 62(6):1068-76. PubMed ID: 23810688
[TBL] [Abstract][Full Text] [Related]
11. [Effects of different decocting methods on quality of Mahuang Xixin Fuzi decoction].
Qiu LL; Li C; Fan SS; Han X; Yang Y; Rong R
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):316-324. PubMed ID: 29552850
[TBL] [Abstract][Full Text] [Related]
12. [The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy].
Xia W; Pei H; Li S; Fu S; Tian L
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):181-5. PubMed ID: 26926368
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and expression of PLA(2)R in renal tissue with idiopathic membranous nephropathy in children].
Dong YF; Sun LW; Zhang B; Kuang XY; Niu XL; Kang YL; Hao S; Wang P; Li Z; Zhu GH; Huang WY; Wu Y
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):206-210. PubMed ID: 29518831
[No Abstract] [Full Text] [Related]
14. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative analysis of the chemical constituents in Mahuang-Fuzi-Xixin decoction based on high performance liquid chromatography combined with time-of-flight mass spectrometry and triple quadrupole mass spectrometers.
Sun Q; Cao H; Zhou Y; Wang X; Jiang H; Gong L; Yang Y; Rong R
Biomed Chromatogr; 2016 Nov; 30(11):1820-1834. PubMed ID: 27183898
[TBL] [Abstract][Full Text] [Related]
17. Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model.
Zheng M; Zhou H; Wan H; Chen YL; He Y
J Ethnopharmacol; 2015 Apr; 164():22-9. PubMed ID: 25660335
[TBL] [Abstract][Full Text] [Related]
18. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
[TBL] [Abstract][Full Text] [Related]
20. Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.
van de Logt AE; Beerenhout CH; Brink HS; van de Kerkhof JJ; Wetzels JF; Hofstra JM
PLoS One; 2015; 10(11):e0142033. PubMed ID: 26562836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
